483 GlaxoSmithKline Biologicals SA Jun 2002

483 GlaxoSmithKline Biologicals SA Jun 2002

Jacqueline Diaz Albert FDA, Sid Priesmeyer FDA$119.00 - Available Now

FDA investigators audited the GlaxoSmithKline Biologicals SA - Rixensart, Belgium facility and issued inspectional observations (via FDA 483) on 24 Jun 2002.

Product details

  • Category: Biologics
  • Inspection end: 24 Jun 2002
  • Location: Rixensart, Belgium
  • FEI: 3002875226
Add To Cart